Pharma Blog Review

Preemption roundup and other bits

August 15, 2008 – 2:27 pm

I am sorry this is late going out. My research and writing were hampered yesterday by some problems with the Pharmalot Website (it was a cache problem, according to site manager Hassan Hodges), interruptions for meetings, and a power outage in the evening at the most recent lot of summer storms rumbled through. While Ed [...]

Posted in Uncategorized | No Comments »

A surfeit of information

August 7, 2008 – 2:07 pm

There were some interesting bits of news over the past seven days to chew over. The U.S. Preventive Services Task Force recommended against routine prostate cancer screening for men over 75; FDA has strengthened its management of FDA advisory committees; members of Congress want Dr. Richard Peto’s analysis of the SEAS data; drug maker Eli [...]

Posted in Uncategorized | No Comments »

When is an important announcement really important?

August 4, 2008 – 2:05 pm

I get a lot of PR people contacting me, probably not as many as some in the media, but my e-mail address and contact information are quite freely available and both magazines (Med Ad News and R&D Directions) are fairly well-known in their niches.
So on Monday, I get this e-mail:
Hi Chris,
I wanted to make sure [...]

Posted in Uncategorized | 1 Comment »

Bapineuzumab not the only news

July 31, 2008 – 12:12 pm

The blogs this week had some chatter about the bapineuzumab results released by Wyeth and Elan, but the big news on Thursday was the offer Bristol-Myers Squibb made for ImClone. The talk about the latter item had not quite made it to the blog level, but followup talk will probably happen for weeks. Looks like [...]

Posted in Uncategorized | 1 Comment »

A surprise bid, a bad surprise for Vytorin, and other bits

July 24, 2008 – 11:21 am

Folks were talking this week about Roche’s surprise bid for Genentech, the results of the most recent clinical trials for Vytorin, and GlaxoSmithKline’s announcement to shift its focus away from prescription drugs. And on a side note, former BrandWeek NRx blogger Jim Edwards has come out of retirement and is blogging again. Welcome back Jim! [...]

Posted in Uncategorized | No Comments »

PhRMA code gets decoded

July 17, 2008 – 11:41 am

I have been remiss about posting earlier this week, but the magazine layout cycle has begun again, and there are pages to read and meetings to attend. But there was a lot of news toward the end of last week and the beginning of this one, primarily the unveiling of PhRMA’s new codes of conduct [...]

Posted in Uncategorized | No Comments »